Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
McKinsey
Medtronic
McKesson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

RAUWOLFIA SERPENTINA Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Rauwolfia Serpentina patents expire, and what generic alternatives are available?

Rauwolfia Serpentina is a drug marketed by Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in RAUWOLFIA SERPENTINA is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.

Summary for RAUWOLFIA SERPENTINA
Drug patent expirations by year for RAUWOLFIA SERPENTINA
Recent Clinical Trials for RAUWOLFIA SERPENTINA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all RAUWOLFIA SERPENTINA clinical trials

US Patents and Regulatory Information for RAUWOLFIA SERPENTINA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bundy RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 009477-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Valeant Pharm Intl RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 009668-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 011521-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Halsey RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080498-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pvt Form RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080583-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs RAUWOLFIA SERPENTINA rauwolfia serpentina root TABLET;ORAL 080914-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
McKesson
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.